Directive 2011/62/EU
E1534936
UNEXPLORED
Directive 2011/62/EU is a European Union law aimed at preventing the entry of falsified medicines into the legal supply chain by strengthening controls and safety features for medicinal products.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Directive 2011/62/EU canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22404544 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2011/62/EU Context triple: [Directive 2001/83/EC, amendedBy, Directive 2011/62/EU]
-
A.
Directive 2007/47/EC
Directive 2007/47/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, active implantable medical devices, and in vitro diagnostic medical devices to improve safety and harmonization across member states.
-
B.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
C.
Directive 2007/60/EC
Directive 2007/60/EC is a European Union law that establishes a framework for assessing and managing flood risks to reduce adverse consequences for human health, the environment, cultural heritage, and economic activity.
-
D.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
E.
Directive 2010/84/EU
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2011/62/EU Target entity description: Directive 2011/62/EU is a European Union law aimed at preventing the entry of falsified medicines into the legal supply chain by strengthening controls and safety features for medicinal products.
-
A.
Directive 2007/47/EC
Directive 2007/47/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, active implantable medical devices, and in vitro diagnostic medical devices to improve safety and harmonization across member states.
-
B.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
C.
Directive 2007/60/EC
Directive 2007/60/EC is a European Union law that establishes a framework for assessing and managing flood risks to reduce adverse consequences for human health, the environment, cultural heritage, and economic activity.
-
D.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
E.
Directive 2010/84/EU
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.